Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Cancer Med. 2018 Nov;7(11):5604-5610. doi: 10.1002/cam4.1779. Epub 2018 Oct 10.
Bladder cancer risk is 3-4 times higher in men than women, but the reason is poorly understood. In mice, male bladder is also more susceptible than female bladder to 4-aminobiphenyl (ABP), a major human bladder carcinogen; however, female liver is more susceptible than male liver to ABP. We investigated the role of sulfotransferase (Sult) in gender-related bladder and liver susceptibility to ABP. Sulfation reactions of aromatic amine bladder carcinogens catalyzed by Sult may generate highly unstable and toxic metabolites. Therefore, liver Sult may decrease bladder exposure to carcinogens by promoting their toxic reactions in the liver. Notably, the expression of several liver Sults is suppressed by androgen in male mice. Here, we show that two Sults are critical for gender-related bladder susceptibility to ABP in mice. We measured tissue level of N-(deoxyguanosin-8-yl)-4-aminobiphenyl (dG-C8-ABP), a principal ABP-DNA adduct, as readout of tissue susceptibility to ABP. We identified Sutl1a1 and to a lesser extent Sult1d1 as Sults that promote dG-C8-ABP formation in hepatic cells. In mice, gender gap in bladder susceptibility to ABP was narrowed by knocking out Sult1a1 and was almost totally eliminated by knocking out both Sutl1a1 and Sult1d1. This was accompanied by dramatic decrease in ABP genotoxicity in the liver (>97%). These results show the strong impact of the Sults on bladder and liver susceptibility to a human carcinogen. Because liver expression of both Sult1a1 and Sutl1d1 is suppressed by androgen in male mice, our results suggest that androgen renders bladder more exposed to ABP in male mice by suppressing Sult-mediated ABP metabolism in liver, which increases bladder delivery of carcinogenic metabolites.
膀胱癌风险在男性中是女性的 3-4 倍,但原因尚不清楚。在小鼠中,雄性膀胱也比雌性膀胱更容易受到 4-氨基联苯(ABP)的影响,ABP 是一种主要的人类膀胱癌致癌物;然而,雌性肝脏比雄性肝脏更容易受到 ABP 的影响。我们研究了磺基转移酶(Sult)在性别相关的膀胱和肝脏对 ABP 易感性中的作用。芳香胺膀胱癌致癌物的磺化反应由 Sult 催化,可能会产生极不稳定和有毒的代谢物。因此,肝脏 Sult 可能会通过促进其在肝脏中的毒性反应,减少致癌物质对膀胱的暴露。值得注意的是,几种肝脏 Sult 的表达在雄性小鼠中受到雄激素的抑制。在这里,我们表明,两种 Sult 在小鼠性别相关的膀胱对 ABP 的易感性中是至关重要的。我们测量了 N-(脱氧鸟嘌呤-8-基)-4-氨基联苯(dG-C8-ABP)的组织水平,作为组织对 ABP 易感性的指标。我们发现 Sutl1a1 和在较小程度上 Sult1d1 是促进肝细胞中 dG-C8-ABP 形成的 Sult。在小鼠中,敲除 Sult1a1 缩小了膀胱对 ABP 的性别差距,而敲除 Sutl1a1 和 Sult1d1 则几乎完全消除了这种差距。这伴随着肝脏中 ABP 遗传毒性的急剧下降(>97%)。这些结果表明 Sult 对膀胱和肝脏对人类致癌物的易感性有很大的影响。由于雄性小鼠肝脏中 Sult1a1 和 Sutl1d1 的表达都受到雄激素的抑制,我们的结果表明,雄激素通过抑制肝脏中 Sult 介导的 ABP 代谢,使雄性小鼠的膀胱更容易接触到 ABP,从而增加了致癌代谢物向膀胱的输送。